311 related articles for article (PubMed ID: 25195008)
21. Proteomics and its applications for biomarker discovery in human saliva.
Xiao H; Wong DT
Bioinformation; 2011 Jan; 5(7):294-6. PubMed ID: 21364838
[TBL] [Abstract][Full Text] [Related]
22. Mass spectrometry-based clinical proteomics.
Pusch W; Flocco MT; Leung SM; Thiele H; Kostrzewa M
Pharmacogenomics; 2003 Jul; 4(4):463-76. PubMed ID: 12831324
[TBL] [Abstract][Full Text] [Related]
23. Saliva diagnostics - Current views and directions.
Kaczor-Urbanowicz KE; Martin Carreras-Presas C; Aro K; Tu M; Garcia-Godoy F; Wong DT
Exp Biol Med (Maywood); 2017 Mar; 242(5):459-472. PubMed ID: 27903834
[TBL] [Abstract][Full Text] [Related]
24. Proteomic advances in salivary diagnostics.
Pappa E; Vougas K; Zoidakis J; Vastardis H
Biochim Biophys Acta Proteins Proteom; 2020 Nov; 1868(11):140494. PubMed ID: 32663525
[TBL] [Abstract][Full Text] [Related]
25. SELDI-TOF mass spectrometry for cancer biomarker discovery and serum proteomic diagnostics.
Simpkins F; Czechowicz JA; Liotta L; Kohn EC
Pharmacogenomics; 2005 Sep; 6(6):647-53. PubMed ID: 16143004
[TBL] [Abstract][Full Text] [Related]
26. Mass spectrometry in high-throughput clinical biomarker assays: multiple reaction monitoring.
Parker CE; Domanski D; Percy AJ; Chambers AG; Camenzind AG; Smith DS; Borchers CH
Top Curr Chem; 2014; 336():117-37. PubMed ID: 22886709
[TBL] [Abstract][Full Text] [Related]
27. Salivary biomarkers for the detection of malignant tumors that are remote from the oral cavity.
Bigler LR; Streckfus CF; Dubinsky WP
Clin Lab Med; 2009 Mar; 29(1):71-85. PubMed ID: 19389552
[TBL] [Abstract][Full Text] [Related]
28. Application of quantitative proteomics technologies to the biomarker discovery pipeline for multiple sclerosis.
Dagley LF; Emili A; Purcell AW
Proteomics Clin Appl; 2013 Jan; 7(1-2):91-108. PubMed ID: 23112123
[TBL] [Abstract][Full Text] [Related]
29. Proteomic analysis of the saliva: a clue for understanding primary from secondary Sjögren's syndrome?
Baldini C; Giusti L; Bazzichi L; Lucacchini A; Bombardieri S
Autoimmun Rev; 2008 Jan; 7(3):185-91. PubMed ID: 18190876
[TBL] [Abstract][Full Text] [Related]
30. SELDI-TOF-MS of saliva: methodology and pre-treatment effects.
Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117
[TBL] [Abstract][Full Text] [Related]
31. The emerging landscape of salivary diagnostics.
Zhang Y; Sun J; Lin CC; Abemayor E; Wang MB; Wong DT
Periodontol 2000; 2016 Feb; 70(1):38-52. PubMed ID: 26662481
[TBL] [Abstract][Full Text] [Related]
32. CE-MS in biomarker discovery, validation, and clinical application.
Mischak H; Schanstra JP
Proteomics Clin Appl; 2011 Feb; 5(1-2):9-23. PubMed ID: 21280234
[TBL] [Abstract][Full Text] [Related]
33. Mass spectrometry-coupled techniques for viral-related disease biomarker identification.
Rhea JM; Diwan CA; Molinaro RJ
Biomark Med; 2010 Dec; 4(6):859-70. PubMed ID: 21133707
[TBL] [Abstract][Full Text] [Related]
34. Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer.
Jou YJ; Lin CD; Lai CH; Chen CH; Kao JY; Chen SY; Tsai MH; Huang SH; Lin CW
Anal Chim Acta; 2010 Nov; 681(1-2):41-8. PubMed ID: 21035601
[TBL] [Abstract][Full Text] [Related]
35. [Mass spectrometry application for clinical diagnostics chairmen's introductory remarks].
Saito K; Nomura F
Rinsho Byori; 2013 Sep; 61(9):803-4. PubMed ID: 24369592
[TBL] [Abstract][Full Text] [Related]
36. Investigation and identification of potential biomarkers in human saliva for the early diagnosis of oral squamous cell carcinoma.
Wang Q; Gao P; Wang X; Duan Y
Clin Chim Acta; 2014 Jan; 427():79-85. PubMed ID: 24144867
[TBL] [Abstract][Full Text] [Related]
37. Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application.
Mischak H; Delles C; Klein J; Schanstra JP
Adv Chronic Kidney Dis; 2010 Nov; 17(6):493-506. PubMed ID: 21044772
[TBL] [Abstract][Full Text] [Related]
38. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
Matta A; Ralhan R; DeSouza LV; Siu KW
Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361
[TBL] [Abstract][Full Text] [Related]
39. A Pilot Proteomic Analysis of Salivary Biomarkers in Autism Spectrum Disorder.
Ngounou Wetie AG; Wormwood KL; Russell S; Ryan JP; Darie CC; Woods AG
Autism Res; 2015 Jun; 8(3):338-50. PubMed ID: 25626423
[TBL] [Abstract][Full Text] [Related]
40. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
Bharti A; Ma PC; Salgia R
Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
